Last reviewed · How we verify
Prometa Treatment Program — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Prometa Treatment Program (Prometa Treatment Program) — Institute of Addiction Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prometa Treatment Program TARGET | Prometa Treatment Program | Institute of Addiction Medicine | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prometa Treatment Program CI watch — RSS
- Prometa Treatment Program CI watch — Atom
- Prometa Treatment Program CI watch — JSON
- Prometa Treatment Program alone — RSS
Cite this brief
Drug Landscape (2026). Prometa Treatment Program — Competitive Intelligence Brief. https://druglandscape.com/ci/prometa-treatment-program. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab